Coral Laboratories Balance Sheet Annual

BSE: 524506 | NSE: - | ISIN: INE683E01017 | Sector: Biotechnology & Drugs

569.80 +21.20 (3.86%)Updated : 05 Oct 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Liabilities Shareholders' Equity	240.66	229.46	205.68	174.35
Accumulated Depreciation Total	-27.48	-28.52	-26.63	-24.90
Other Liabilities Total	0.73	0.75	0.72	5.15
Accrued Expenses	0.99	0.90	-	-
Common Stock Total	3.57	3.57	3.57	3.57
Other Current Assets Total	71.21	76.64	59.42	34.43
Prepaid Expenses	0.12	0.07	0.09	0.09
Total Assets	240.66	229.46	205.68	174.35
Cash	1.37	3.41	2.07	6.13
Total Equity	209.11	201.21	177.50	154.80
Long Term Investments	17.68	25.72	27.08	20.54
Retained Earnings( Accumulated Deficit)	190.95	175.11	173.92	151.23
Total Common Shares Outstanding	0.36	0.36	0.36	0.36
Property/ Plant/ Equipment Total- Gross	70.69	52.75	49.90	49.18
Tangible Book Valueper Share Common Eq	585.17	563.00	496.65	433.24
Total Liabilities	31.55	28.26	28.18	19.55
Total Debt	4.33	3.56	0.00	0.00
Short Term Investments	29.33	27.54	25.72	23.88
Cashand Short Term Investments	30.70	30.95	27.79	30.01
Total Receivables Net	52.99	53.25	49.84	46.09
Notes Payable/ Short Term Debt	4.33	3.56	0.00	0.00
Deferred Income Tax	3.51	2.55	2.57	2.54
Accounts Receivable- Trade Net	29.43	33.64	28.19	23.42
Property/ Plant/ Equipment Total- Net	43.21	24.23	23.27	24.28
Total Current Liabilities	27.31	24.96	24.90	11.86
Total Inventory	21.96	15.63	16.72	12.93
Accounts Payable	10.02	6.62	13.24	4.21
Other Currentliabilities Total	11.97	13.88	11.66	7.65
Total Long Term Debt	0.00	0.00	0.00	0.00
Intangibles Net	0.06	0.07	0.06	0.02
Other Long Term Assets Total	2.13	2.31	1.06	5.61
Note Receivable- Long Term	0.62	0.59	0.35	0.35
Unrealized Gain( Loss)	14.59	22.53	-	-
period Length	0.00	0.00	0.00	0.00
Total Current Assets	176.97	176.55	153.85	123.54